Background/Aims: Three rare MAPK7 variants that predispose individuals to adolescent idiopathic scoliosis have previously been identified. However, the mechanism underlying the effects of the mutations remain unknown. Methods: Human mesenchymal stem cells (hMSCs) were isolated from both patients and healthy volunteer donors, and MAPK7 expression was detected by western blotting and real-time quantitative PCR (RT-qPCR). Zebrafish embryos were injected with mapk7 morpholinos or co-injected with morpholinos and wild-type (WT) MAPK7 messenger RNA (mRNA) at the one-cell stage, followed by calcein staining to evaluate bone formation. hMSCs were transfected with MAPK7 small interfering RNAs and osteogenesis was induced for 14 days. Alizarin red staining was performed and osteoblast markers were detected by western blotting and RT-qPCR. Since RPS6KA3 is a downstream target of MAPK7 and plays an important role in the osteogenesis, zebrafish embryos were then injected with rps6ka3 morpholinos, or co-injected with rps6ka3 or mapk7 morpholinos and WT RPS6KA3 mRNA at the one-cell stage. Results: MAPK7 expression in the patient group was much lower than in the control group. Morpholino-induced mapk7 knockdown in zebrafish embryos led to body curvature, which was significantly reversed by WT MAPK7 mRNA. Calcein staining revealed that mapk7-knockdown delayed the ossification of the vertebrae. MAPK7 silencing in hMSCs impaired osteogenesis and downregulated osteoblast marker expression. Morpholinoinduced rps6ka3-knockdown in zebrafish embryos led to body curvature, which was reversed by WT RPS6KA3 mRNA. Interestingly, RPS6KA3 mRNA also partially reversed the phenotype
Introduction
Adolescent idiopathic scoliosis (AIS) is an intricate genetic disorder characterised by a three-dimensional structural deformity as well as lateral curvature of the spine. AIS afflicts 2-3% of school-age children and accounts for about 85% of all idiopathic patients [1] . Previous studies have revealed a strong genetic etiology, and recent genome-wide association studies and whole exome sequencing (WES) studies have identified several variants in genes associated with AIS, such as GPR126 [2] , BNC2 [3] , PAX1 [4] , LBX1AS1 [5] , POC5 [6] , and AKAP2 [7] . However, the precise biological pathways underlying the predisposition of these variants to AIS are unknown. Prior evaluations have shown that AIS patients have atypical skeletal growth [8] and consistently lower bone mineral densities [9] than those of sex-and age-matched controls. Furthermore, relative anterior overgrowth with disproportionate endochondral-membranous bone growth contributes to the development of AIS [10] . Mesenchymal stem cells (MSCs) are multipotent stromal cells that can differentiate to bone, cartilage and adipose cells. Intramembranous and endochondral ossification, two important components of bone formation, begin with MSC proliferation and condensation [11] . A previous study has reported that MSCs from patients with AIS undergo abnormal osteogenic differentiation [12] .
Recently, we determined rare AIS-predisposing variants in the MAPK7 gene (which encodes mitogen-activated protein kinase 7) by WES along with a linkage screen, followed by targeted sequencing in the Han Chinese population [13] . MAPK7, also termed extracellular signal-regulated kinase 5 (ERK5), is part of the MAP kinase family. Numerous evaluations have demonstrated that classical RAS/MAPK signaling, including RAS, RAF, MEK1/2, and ERK1/2, is required for typical skeletal growth, and variation in this pathway can lead to several skeletal abnormalities in humans, including scoliosis [14] [15] [16] .
In addition, functional cross talk of MAPK7 with the RAS-RAF-MEK1/2-ERK1/2 signaling pathway has been documented. The activation of the MAPK7 catalytic domain by RAS and the binding of MAPK7 and RAF-1 have also been detected [17] . In addition, SHP2, a positive regulator of RAS-MAPK signaling, leads to MAPK7 initiation via its role in SRC kinase activation [18] . The chondrocyte-specific deletion of shp2 can cause the disorganization of the vertebral growth plate and lead to AIS-like deformities in mice [19] . Mutations in RPS6KA3, encoding a downstream effector of MAPK7 [20] , contribute to Coffin-Lowry syndrome, which causes kyphosis and/or scoliosis in 80% of patients [21] . Importantly, Nkx3.1:Credriven mapk7 deletion in mice result in a severely curved spine and substantially reduced bone mass/osteopenia [22] .
Therefore, to investigate the mechanisms underlying the role of MAPK7 in idiopathic scoliosis, mapk7 and rps6ka3 were knocked down in zebrafish embryos using morpholinos, and MAPK7 was silenced in hMSCs using siRNAs.
Materials and Methods

Participants
This study was approved by the Ethical Committee of the First Affiliated Hospital of Sun Yat-sen University, and written informed consent was obtained from Patient 1 (carrying the MAPK7 c.886G>A variant), Patient 2 (carrying the MAPK7 c.1943C>T variant), and healthy subjects. Subjects were evaluated by three surgeons from the First Affiliated Hospital of Sun Yat-sen University and met the current clinical criteria for AIS [23] .
Isolation and culture of bone marrow-derived hMSCs hMSCs were separated from the bone marrow of patients and healthy donors and cultured as detailed previously [24] . In brief, the bone marrow samples were diluted with phosphate-buffered saline (PBS), and the cells were then fractionated using Lymphoprep (MP Biomedicals, LLC, Santa Ana, CA, USA) density gradient medium. Cells were then resuspended in low-glucose Dulbecco's modified Eagle medium (DMEM; Thermo Fisher Scientific, Waltham, MA, USA) and supplemented with 10% fetal bovine serum (FBS; Thermo Fisher Scientific), They were then seeded and incubated at 37°C with 5% CO 2 . After 48 h, non-adherent cells were eliminated by changing the medium. Then, the medium was changed after every 3 days. When the cells reached 80-90% confluence, they were trypsinized, counted, and re-plated. The cells from passage days 3-6 were utilized in the experiments.
Immunoblotting
Cells were washed twice with ice cold PBS, harvested, and resuspended in RIPA lysis buffer (Beyotime, Shanghai, China) along with the protease inhibitor cocktail (Biotool, Houston, TX, USA). Cell lysates were acquired by centrifugation at 14, 000 × g for 15 minutes at 4°C. Identical portions of every sample were subjected to sodium dodecyl sulfate -polyacrylamide gel electrophoresis and then moved to Polyvinylidene fluoride transfer membranes (Millipore, Boston, MA, USA). Membranes were blocked with 5% nonfat dry milk for 1 h at room temperature and then incubated with the specified antibodies. Antibody-specific labeling was observed by incubation with horseradish peroxidase (HRP)-conjugated secondary antibodies for 1 h at room temperature, and visualization was performed using an ECL kit (Millipore). The band strength was determined with ImageJ software (National Institutes of Health, Bethesda, MD, USA) and normalized to GAPDH as the loading control.
Primary antibodies against MAPK7, RPS6KA3 (RSK2), p-RPS6KA3 (p-RSK2), RUNX2, and α-Tubulin were acquired from Cell Signaling Technology (Danvers, MA, USA). Antibodies against Osteopontin (OPN) and GAPDH were obtained from Abcam (Cambridge, UK). Goat anti-rabbit IgG H&L (HRP) and goat antimouse IgG H&L (HRP) secondary antibodies were obtained from Thermo Fisher Scientific.
Real-time quantitative PCR assay
Total RNA was extracted with an e.Z.N.A ® Total RNA Kit I (Omega Bio-Tek, Norcross, GA, USA) from hMSCs and then reverse transcibed to cDNA with Superscript IV VILO Mastermix (Thermo Fisher Scientific) according to the manufacturer's instructions. Real-time PCR was conducted on a Light Cycler 480 RealTime PCR Detection System (Roche, Basel, Switzerland) utilizing SYBR Green I Master Mix (Roche). The expression levels of MAPK7, RUNX2, ALP, and SSP1 were determined. The glyceraldehyde-3-phosphate dehydrogenase (GAPDH) expression level was used as the reference. Every PCR was processed in triplicate. The relative expression levels for each gene were established utilizing the 2 -∆∆Ct method. The primer sequences utilized in this evaluation are included in Table 1 .
Plasmid construction and MAPK7 siRNA WT versions of human MAPK7 mRNA and RPS6KA3 mRNA were produced from a flag-tagged ORF clone of human MAPK7 (Origene, Beijing, China). mRNAs were obtained from linearized constructs as previously reported [25] . The negative control and MAPK7 siRNAs (MAPK7 siRNA-1: GCTCAAGATTGGTGACTTT, and MAPK7 siRNA-2: GCTCAAGATTGGTGACTTT) were obtained from Ribobio (Guangzhou, China). hMSCs were transfected with siRNA using RNAiMAX Transfection Reagent (Thermo Fisher Scientific) according to the manufacturer's protocol. 
Zebrafish embryo injection
Embryos of the AB strain of zebrafish (Danio rerio) were raised and maintained as described previously [26] after obtaining permission from the Ethics Committee of the First Affiliated Hospital of Sun Yat-sen University. Embryos were staged based on the number of hours post-fertilization (hpf) or days postfertilization (dpf) at 28.5°C. A splice-blocking morpholino (MO), 5'-TCATCCATCTTATTGGATGCCATCC-3', was designed to target the acceptor splice site of intron 4 of the mapk7 gene (Gene Tools LLC, Philomath, OR, USA). A splice-blocking MO, 5'-AGAATGTGGCAGCCATCGCCCCCTA-3', was designed to target the splice acceptor site of intron 16 of the rps6ka3 gene. The sequence of the standard control MO was 5'-CCTCTTACCTCAGTTACAATTTATA-3'. Then, 4 ng of MO and/or 100 pg of mRNA was injected into WT zebrafish embryos (N≥100 for each group) at the one-cell stage. Whole embryo images were obtained using a Leica M205FA stereomicroscope (Leica Microsystems, Wetzlar, Germany), and a morphological analysis on the physical changes in the injected embryos, including body curvature and other skeletal malformations, was performed at 4 dpf.
Semi-quantitative reverse transcription (RT-PCR) was conducted to determine the mRNA expression of mapk7. In brief, total RNA was isolated at 48 hpf with RNAiso Plus (Clontech Laboratories, Inc., Fremont, CA, USA) following the manufacturer's instructions. cDNA was synthesized from 0.3-1 µg of total RNA utilizing a Thermo Fisher Scientific Maxima First Strand cDNA Synthesis Kit (Thermo Fisher Scientific). The gene-specific primer sequences are included in Table 1 . The samples were resolved by electrophoresis on 2.0% agarose gel.
Calcein staining Calcein (C 30 H 26 N 2 O 13 ; Sigma Aldrich, St. Louis, MO, USA) was used to stain calcified bone. Immersion solutions (0.2%) were set up by dissolving 2 g of calcein powder in 1 L of deionized water. Owing to the intense acidifying impact of calcein, a suitable portion of NaOH (0.5 N) was added to the solution to adjust the pH to its initial value. Zebrafish embryos were netted and immersed in the solution for 20 min in Petri dishes. After immersion, the embryos were rinsed several times in fresh water and then immersed in fresh water for 10 min to let the extra unbound calcein spread out of tissues. The embryos were then killed in tricaine-methanesulfonate (Sigma Aldrich) and mounted on glass slides with 3% methyl-cellulose (Sigma Aldrich). Whole embryo images were obtained using a Leica M205FA stereomicroscope.
Osteogenic differentiation
Prior to osteogenic differentiation, MSCs were plated and grown in complete medium until they reached 70%-80% confluence. They were then cultured in osteogenic medium for 14 days. The osteogenic medium consisted of low-glucose DMEM, 10% FBS, 0.1 μmol/L dexamethasone, 10 mmol/L β-glycerol phosphate, and 50 μg/mL ascorbic acid, and the medium was changed every 3 days.
Alizarin Red S staining
Following the induction of osteogenic differentiation for 14 days, the cells were rinsed twice with PBS and fixed in 4% formaldehyde for 30 min. Then, the cells were stained with 0.2% Alizarin Red S solution (Sigma-Aldrich) for 5 min at 37°C. The cells were then cleansed thrice with PBS and imaged were obtained. The red color indicated calcium deposits. Stains were eluted with 100% dimethyl sulfoxide (Sigma-Aldrich) to establish the amount of Alizarin red staining and absorbance was measured at 405 nm. Every experiment was conducted in triplicate.
Statistical analysis
All quantitative results are presented as means ± standard deviation (SD). Statistical analyses was performed utilizing two-tailed independent Student's t test for comparisons between two groups and oneway analysis of variance and Dunnett's post-hoc tests for multiple comparisons. All statistical analyses were performed using SPSS 20.0 (SPSS, Chicago, IL, USA). The level of statistical significance was established at P < 0.05.
Zebrafish embryos with mapk7-morpholino knockdown exhibited body curvature
Since vertebrate spines have astonishing similarities between species, and MAPK7 is highly conserved among humans and zebrafish (amino acid identity, 73%), we evaluated the role of MAPK7 in skeletal development in the zebrafish model. We injected zebrafish embryos with an MO designed to target the splice acceptor site of intron 4 of the mapk7 gene ( Fig. 2A ). An RT-PCR analysis of the mapk7 MO-injected embryos showed that exon 5 of the mapk7 gene was skipped ( Fig. 2A-B) . Since exon 5 encodes the majority of the mapk7 kinase domain, its skipping is assumed to result in a nonfunctional product. Three days postfertilization, body curvature was observed in the morphants, and co-injection of human WT MAPK7 mRNA significantly reversed the phenotype (Fig. 2 C-D) . RT-qPCR revealed that the MAPK7 mRNA levels in patients were much lower than those in the control group. (C and D) MAPK7 protein levels in the patient group were much lower than those in the control group. Band strength was quantified using ImageJ and normalized to the levels of GAPDH as the loading control. 
Zhou et al.: MAPK7-Scoliosis is Linked to Impaired Osteogenesis
To examine whether there are any defects in osteogenesis in the mapk7 knockout zebrafish model, ossification of the vertebrae in the morphants was examined at 14 dpf by calcein staining. The numbers of ossified vertebrae in the morphants decreased significantly in response to mapk7 MOs (Fig. 2E-F) .
Knockdown of MAPK7 impaired osteogenesis in hMSCs
To further investigate the role of MAPK7 in the process of osteogenesis, the MAPK7 gene was silenced using siRNA in hMSCs from healthy donors. The siRNA efficiency was examined by RT-qPCR and western blotting (Fig. 3A-B) . hMSC differentiation into osteoblasts was then induced and Alizarin Red staining was performed and quantified at day 14. MAPK7 silencing led to an impaired osteogenic capacity in the hMSCs (Fig. 3C-D) . RT-qPCR revealed that the (Fig. 3E) . Osteogenic marker proteins and their downstream molecules were then detected by western blotting. MAPK7 siRNA downregulated both RUNX2 and OPN during the osteogenic process (Fig. 3F) . However, MAPK7 siRNA led to reduced phosphorylation of RPS6KA3 (RSK2), instead of affecting the protein expression of total RPS6KA3 (Fig. 3F) .
Overexpression of rps6ka3b mRNA reversed the body curvature of mapk7 morphants
To further investigate the role of rps6ka3 in the body curvature caused by mapk7 knockdown, we injected zebrafish embryos with an MO designed to target the splice acceptor sites of introns 16 and 20 of rps6ka3 (Fig. 4A ). An RT-PCR analysis of the MO-injected embryos showed that exons 17-20 of rps6ka3 were skipped (Fig. 4 A-B) . Since exon 17 and exon 21 encode the majority of the mapk7 phosphorylation and docking sites, respectively, its skipping is expected to result in the failure of mapk7 binding to rps6ka3. Body curvature was observed in both types of morphants at 4 dpf (Fig. 4C) , and the co-injection of WT rps6ka3 mRNA significantly reversed the phenotype (Fig. 3D) . Importantly, the co-injection of WT rps6ka3 mRNA with mapk7 morpholinos partially reversed the body curvature (Fig. 4D) . Therefore, the loss of function of mapk7 may lead to idiopathic scoliosis partly by impairing the activation of the rps6ka3 protein.
Discussion
Previously, we reported that three rare MAPK7 variants predispose individuals to AIS. However, the underlying mechanism remains unknown. In this study, we evaluated the functional changes associated with two of these variants using hMSCs from patients. RT-qPCR and western blotting showed that the MAPK7 c.886G>A and MAPK7 c.1943C>T variants lead to low MAPK7 expression. Thus, we focused on the effects of the loss of MAPK7 on the development of the skeletal system.
MAPK7 plays a crucial role in vertebrate embryogenesis, and gene disruption is lethal during mouse development [27, 28] . Very recently, the loss of Mapk7 as a result of Nkx3.1-Cre was linked to a severe spinal deformity and an osteopenic phenotype. In this model, a curled tail phenotype was noted in approximately 30% of Erk5 fl/fl mice [29] . In our study, we found that knocking down mapk7 in zebrafish embryos results in a scoliosis-like body curvature, and this could be reversed by co-injection with human WT MAPK7 mRNA.
AIS is the most frequently noted spinal deformity, and prior evaluations have demonstrated that the vertebrae in scoliotic spines exhibit atypical shape changes that are possibly impacted by the bone density distribution inside the vertebrae. A low bone mass and osteopenia have been reported in the axial and peripheral skeletons of patients with AIS. The z-score for BMD at the femoral neck of the subjects with AIS was significantly lower than that of the normal controls. In addition, the patients with AIS had irregular bone quality with a greater prevalence of osteopenia [30] . Biomechanical simulation indicated that a low bone mineral mass may aggravate curve progression and induce more serious lumbar compensatory scoliosis in patients with AIS [31] . At the apical vertebra, the mean bone density at the concave side of the cortical shell was 23.5% greater than that of the convex cortical shell, and the cancellous bone density along the central 60% of the lateral path from convex to concave increased by 13.8% [32] . A substantially deformed curved thoracic spine, with a linked loss of trabecular bone volume, was also noted in the above-mentioned Erk5 fl/fl mice. Importantly, we observed delayed ossification of the vertebrae in the morphants at 14 dpf, suggesting that abnormal bone formation plays an important role in the mutant mapk7-induced phenotype.
ERK5 (MAPK7) is activated downstream of MAP2K MEK5 (MAP2K5). ERK1/2, ERK5, p38, and JNK comprise the conventional group of MAPKs based on the conservation of the Thr-Xaa-Thr motif in the activating loop [33] . Li et al [34] . provided novel insights into the mechanisms underlying mechanosensation by highlighting the association between MAPK7 Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry activation and cytoskeletal reorganization in osteoblasts experiencing fluid shear stress (FSS). MAPK7 was quickly phosphorylated in pre-osteoblastic MC3T3-E1 cells upon the occurrence of FSS. The integrity and reorganization of the cytoskeleton were pivotal in this process, in which the cytoskeleton-dependent activation of FAK (focal adhesion kinase) was involved in the FSS-induced initiation of MAPK7. The MEK5/ERK5 pathway also regulates FSS-induced Runx-2 expression in osteoblast differentiation, and the expressions of Cyclin B1 and CDK1 may also be upregulated, causing MC3T3-E1 cell proliferation [35, 36] . Mekk3 (Mek kinase 3) encodes an upstream kinase of MEK5; it has been linked to bone mineral density prompted by M-CSF in an oligonucleotide microarray examination of gene expression patterns in mouse bone marrow mononuclear cells during the process of osteoclast differentiation [37, 38] . Mekk2, a kinase downstream of the ERK5 pathway, is also essential in the regulation of osteoblast activity [39] . The atypical expression of Runx2 and reduced BMD in patients with AIS suggest the abnormal regulation of osteoblast differentiation. Runx2 could have a critical role in the pathogenesis of the reduced BMD in AIS [40] . In our study, the silencing of MAPK7 by siRNA impaired osteogenesis in hMSCs, and significantly down-regulated the expression of RUNX2.
Coffin-Lowry syndrome is a unique X-linked disorder in which males present with severe mental delays and dysmorphism (approximately 80% exhibit kyphosis and/or scoliosis) [21] . It results from mutations in the RPS6KA3 gene located at Xp22.2, which encodes RSK2, a growth-factor-regulated protein kinase. RPS6KA3 mutations are exceedingly heterogeneous and cause the loss of phosphotransferase activity in the RSK2 kinase, most frequently due to early translation termination [41] . MAPK7 can specifically activate RPS6KA3 in vitro, and the activation of MAPK7 weakens its binding to RSK2, indicating that RPS6KA3 is liberated at activation [20] . ATF4 is a pivotal substrate of RPS6KA3 and is needed for the timely onset of osteoblast differentiation, the terminal differentiation of osteoblasts, and osteoblast-specific gene expression. Furthermore, RSK2 and ATF4 post-transcriptionally mediate the synthesis of Type I collagen, the prominent constituent of the bone matrix. Thus, an Atf4-deficiency results in later bone formation during embryonic development and diminished bone mass during postnatal life [42] . The large C-terminal domain of MAPK7 is not needed for the binding or activation of RPS6KA3 by MAPK7; however, the common docking (CD domain) of MAPK7 and the docking (D domain) of RSK are necessary for their association [20] . Prior evaluations have demonstrated that mice without RPS6KA3 develop osteopenia due to damaged osteoblast function and normal osteoclast differentiation. This phenotype is linked to reduced expression of Phex, an endopeptidase that mediates bone mineralization [43] . By targeting the ERK docking and phosphorylation sites using rps6ka3 MOs, we successfully replicated the body curvature in zebrafish embryos. Importantly, the co-injection of mapk7 MO and WT human RPS6KA3 mRNA significantly prevented this phenotype, suggesting that mutant MAPK7 contributes to idiopathic scoliosis partly via RPS6KA3.
In conclusion, the results of this study revealed the critical part of Mapk7 in bone development and homeostasis in vivo and in vitro. The loss of Mapk7 was linked to extreme spinal deformity and an impaired osteogenesis phenotype. In addition, our results suggest that the reduction of MAPK7 pathway activity and the loss of MAPK7 gene expression induce damaged osteogenesis via RPS6KA3 and/or its substrates. This model broadens our knowledge and understanding of the molecular events that mediate bone homeostasis, spinal deformities, and/or osteopenia.
